CYTL1 and breast carcinoma: Wang et al. [14] concluded through bioinformatics that CYTL1 is usually hypermethylated in breast cancer and lung cancer; high CYTL1 expression has no significant effect on the proliferation of lung cancer but inhibits migration and invasion of lung cancer.